KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Finished Goods (2018 - 2025)

ClearPoint Neuro's Finished Goods history spans 12 years, with the latest figure at $3.5 million for Q3 2025.

  • For Q3 2025, Finished Goods changed N/A year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, changed N/A, while the annual FY2024 figure was $3.6 million, 193.27% up from the prior year.
  • Finished Goods for Q3 2025 was $3.5 million at ClearPoint Neuro, up from $3.4 million in the prior quarter.
  • Across five years, Finished Goods topped out at $3.6 million in Q4 2024 and bottomed at $664000.0 in Q1 2025.
  • The 4-year median for Finished Goods is $1.5 million (2021), against an average of $2.1 million.
  • The largest annual shift saw Finished Goods decreased 15.07% in 2021 before it surged 193.27% in 2024.
  • A 4-year view of Finished Goods shows it stood at $1.4 million in 2021, then dropped by 13.04% to $1.2 million in 2023, then soared by 193.27% to $3.6 million in 2024, then dropped by 4.01% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Finished Goods are $3.5 million (Q3 2025), $3.4 million (Q2 2025), and $664000.0 (Q1 2025).